Fred H Mermelstein

Title: The Innovator Fred H. Mermelstein: Advancements in Analgesics

Introduction

Fred H. Mermelstein, an accomplished inventor based in Newtown, MA, has made significant contributions to the field of pharmaceutical sciences. With two patents to his name, Mermelstein focuses on innovative formulations that enhance the efficacy and safety of analgesic medications.

Latest Patents

Among his latest patents, Mermelstein has developed formulations of low-dose diclofenac combined with beta-cyclodextrin. One patent describes a pharmaceutical composition containing a diclofenac compound effective for inducing analgesia at a dose of less than 75 mg, specifically ranging from about 18.75 mg to about 37.5 mg. This formulation aims to provide effective pain relief while minimizing potential side effects. Another patent details a formulation where the diclofenac compound is present at less than 10 mg, again focusing on methods of treating subjects in need of analgesia. These innovations represent a promising evolution in pain management therapies.

Career Highlights

Throughout his career, Mermelstein has worked with several prominent companies, including Javelin Pharmaceuticals, Inc. and Hospira, Inc. His roles in these organizations have likely contributed to his extensive knowledge and expertise in pharmaceutical formulations and drug development.

Collaborations

Mermelstein's journey in the pharmaceutical industry has introduced him to several notable colleagues, including Curtis Wright and Daniel B. Carr. Collaborations with such professionals have undoubtedly enriched his work and fostered innovative ideas in analgesic therapies.

Conclusion

Fred H. Mermelstein's contributions to pain management through his novel formulations of diclofenac exemplify the vital role inventors play in advancing medical research and pharmaceutical development. His innovative approach not only enhances patient care but also sets the stage for future breakthroughs in pain relief.